Showing 1491-1500 of 2526 results for "".
- Roche’s Genentech Unit to Cut 223 Jobs in UShttps://modernod.com/news/roches-genentech-unit-to-cut-223-jobs-in-us/2479930/Roche’s Genentech unit plans to cut 223 jobs from its South San Francisco, California headquarters by the end of the year. The company, which disclosed the staff reductions in a Worker Adjustment and Retraining Notification (WARN) posted by the State of California’s Employment Develop
- UnitedHealthcare Eye Care Program Aims to Give Children Access to Comprehensive Eye Exams and Glasseshttps://modernod.com/news/unitedhealthcare-eye-care-program-aims-to-give-children-access-to-comprehensive-eye-exams-and-glasses/2479940/UnitedHealthcare has launched a new program that aims to improve access to comprehensive eye exams and prescription glasses for children across the country, helping address the unique eye-health challenges young people face. The UnitedHealthcare Children’s Eye Care Program will help expand
- Unsafe Ocular Stem Cell Treatments Prevalenthttps://modernod.com/news/unsafe-ocular-stem-cell-treatments-prevalent/2479976/Experimental stem cell therapies for eye conditions are being offered at dozens of unregulated clinics in the United States, and some of these procedures are harmful, researchers report. Clinicians should warn their patients against
- Q Biomed Extends its Exclusive Option Agreement With Washington University for Glaucoma Detection Biomarkerhttps://modernod.com/news/q-biomed-extends-its-exclusive-option-agreement-with-washington-university-for-glaucoma-detection-biomarker/2479989/Q BioMed has announced that it is extending its option agreement with Washington University in St. Louis. Under the agreement granting the exclusive right to license the technology, Q BioMed will continue to evaluate the feasibility and
- Novartis Chairman Says Alcon Worth $20 Billion to $30 Billion: Finanz und Wirtschafthttps://modernod.com/news/novartis-chairman-says-alcon-worth-20-billion-30-billion-finanz-und-wirtschaft/2480052/The chairman of Swiss Novartis expects Alcon to be valued at between $20 billion and $30 billion when the ophthalmic devices unit is spun off to shareholders next year, he said in an interview with Finanz und Wirtschaft, according to a Reuters
- Zeiss Unveils Visulas Green Photocoagulation Laser at WOChttps://modernod.com/news/zeiss-unveils-next-generation-of-ophthalmic-laser-visulas-green-at-world-ophthalmology-congress/2480074/Zeiss unveiled its next-generation Visulas green photocoagulation laser at the World Ophthalmology Congress in Barcelona. Visulas green offers uninterrupted workflow by giving doctors the ability to monitor treatment settings directly from the eyepiece and the abi
- RightEye Unveils EyeQ Trainer Personalized Computer-Based Vision Training Systemhttps://modernod.com/news/righteye-unveils-eyeq-trainer-personalized-computer-based-vision-training-system/2480076/RightEye unveiled its new EyeQ Trainer computer-based vision rehabilitation program at Optometry’s Meeting 2018 in Denver, Colorado (RightEye booth #611). EyeQ Trainer gives optometrists a tool their
- Optos Unveils Monaco Ultra-Widefield Imaging Device with OCT Capabilitieshttps://modernod.com/news/optos-unveils-monaco-ultra-widefield-imaging-device-with-oct-capabilities/2480175/Optos has announced that Monaco, which the company describes as the first ultra-widefield imaging device combined with OCT, was launched Thursday in the United States. Monaco is a compact desk-top UWF retinal imaging device that provides greater imaging functionality and expands the compan
- Allergan CEO: Large Deal Would Be An Unlikely Outcome of Reviewhttps://modernod.com/news/allergan-ceo-large-deal-would-be-an-unlikely-outcome-of-review/2480196/Allergan Chief Executive Brent Saunders said on Monday that while the company is considering large, transformational deals as part of a strategic review, they are a “very low priority and a very unlikely outcome” of the process, according to a Reuters
- Akorn Asks Delaware Court to Require Fresenius Kabi to Fulfill Its Obligations Under Merger Agreementhttps://modernod.com/news/akorn-asks-delaware-court-to-require-fresenius-kabi-to-fulfill-its-obligations-under-merger-agreement/2480214/Akorn filed a complaint in Delaware Chancery Court asking that Fresenius Kabi AG be required to fulfill its obligations under the definitive merger agreement, and issued the following statement: “Fresenius’ attempt to terminate the transaction on the pretext that the findings from the ongo